DTL
CVAC

Dynamic Technology Lab’s CureVac CVAC Stock Holding History

Dynamic Technology Lab’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-37,931
Closed -$160K – 1106
2023
Q4 		$160K Buy
+37,931
New +$206K 0.02% 909
2022
Q2 		– Sell
-14,181
Closed -$278K – 1205
2022
Q1 		$278K Buy
+14,181
New +$283K 0.03% 820

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Dynamic Technology Lab's CVAC Position: Q1 2024 in Review

Dynamic Technology Lab sold out of CureVac (CVAC) in Q1 2024, closing a stake of 37,931 shares — an estimated $160K sold.

Dynamic Technology Lab first reported a position in CVAC in Q1 2022 and held it in 2 quarters. The position peaked at $278K in Q1 2022. 90 funds tracked by Wall St. Rank hold CVAC as of Q1 2024.

  • Dynamic Technology Lab reported no remaining CureVac position as of Q1 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 37,931 CureVac shares in Q1 2024, an estimated $160K.
  • Dynamic Technology Lab first reported a position in CureVac in Q1 2022 and held it in 2 quarters.
  • Dynamic Technology Lab's CureVac position peaked at $278K in Q1 2022.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.